Amifampridine Phosphate
LMS-002
Phase 3 small_molecule completed
Quick answer
Amifampridine Phosphate for Lambert Eaton Myasthenic Syndrome is a Phase 3 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Lambert Eaton Myasthenic Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed